摘要
新近发现的抑癌基因 PTEN/MMAC1/TEP1是子宫内膜癌中突变率最高的基因,也称子宫内膜的看家基因,其功能丧失视为子宫内膜癌的早期分子事件。PTEN 基因在不同的细胞类型及肿瘤发生发展的不同阶段扮演不同的角色,发挥不同的抑癌作用。综述该领域的最新进展。
出处
《国外医学(妇产科学分册)》
2002年第5期290-292,共3页
Foreign Medical Sciences(Obstet Gynecol Fascicle)
参考文献19
-
1Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer.Science,1997,275(5308):1943-1947
-
2Steck PA,Pershouse MA,Jasser SA,et al.Identification of a candidate tumor suppressor gene MMAC1,at chromosome 10q23.3 that is mutated in multiple advanced cancers.Nat Genet,1997,15(4):356-363
-
3Li DM,Sun H.Tepl,encoded by a candidate tumor suppressor locus,is a novel protein tyrosine phosphstas regulated by transforming growth factor beta.Cancer Res,1997,57(11):2124-2129
-
4Fernandez M,Eng C.Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells.Clin Cancer Res,2002,8(6):1904-1914
-
5Cristofano AD,Pandolfi PP.The multiple rule of PTEN in tumor suppression.Cell,2000,100(4):387-390
-
6Yuan XJ,Whang YE.PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.Oncogene,2002,21(2):319-327
-
7Weng LP,Smith WM,Brown JL,et al.PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.Hum Mol Genet,2001,10(3):237-242
-
8Ikeda T,Yoshinaga K,Suzuki A,et al.Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer.Oncol Rep,2000,7(3):567-570
-
9Maxwell GL,Risinger JI,Alvarez AA,et al.Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.Obstet Gynecol,2001,97(3):417-422
-
10Tashiro H,Blazes MS,Wu R,et al.Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.Cancer Res,1997,57 (18):3935-3940
同被引文献10
-
1Maxwell G L, Risinger J I, Gumbs C, et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias[J].Cancer Res, 1998, 58(12): 2500-2503.
-
2Levine R L, Cargile C B, Blazes M S, et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma[J]. Cancer Res, 1998, 58(15):3254-3258.
-
3Cantely L C, Neel B C. New insight into tumor suppression:PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway[J]. Proc Natl Acad Sci USA, 1999,96(8) :4240-4245.
-
4Mutter G L, Lin M C, Fitzgerald J T, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancer[J]. J Natl Cancer Inst, 2000, 92(11): 924-931.
-
5Yamada K M, Arad M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis[J]. J Cell Sci,2001,114(pt13):2375- 2382.
-
6曹译毅.中华妇产科学[M].北京:人民卫生出版社,1999.389.
-
7Kutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers[J].J Natl Cancer Inst,2000,92(11) :924-931
-
8Lisinger JI,Hayes AK,Berchuck A,et al. PTEN/MMAC1 mutations in endometrial cancers [J ]. Cancer Res, 1997, 57 ( 21 ) :4 736-4 738
-
9Lu thalakath H, H uang DC, O' Reilly LA, et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex[J]. Mol Cell, 1999,3 (3) :287-296
-
10邹伟,李兆育,李春蕾,崔肇春.蛋白激酶B及其在磷脂酰肌醇3-激酶介导的信号转导中的作用[J].生理科学进展,2000,31(2):120-124. 被引量:11
引证文献2
-
1杨清,王玉,张淑兰,张静.PTEN/PI3K信号转导途径与子宫内膜癌生物学行为的相关性[J].肿瘤防治杂志,2004,11(6):569-572. 被引量:4
-
2张静,叶飞,朱志洁,陈丽春.PTEN,Bim蛋白在子宫内膜癌中的表达及意义[J].齐齐哈尔医学院学报,2006,27(8):918-919. 被引量:1
二级引证文献5
-
1杨清,张淑兰,王玉.子宫内膜癌组织中p-PKB及仅含BH3域蛋白的表达及其相关性[J].中国肿瘤临床,2006,33(16):912-915. 被引量:5
-
2席广民,牛瑞芳.PI3K-Akt信号通路阻断在乳腺癌治疗中的作用[J].中华肿瘤防治杂志,2007,14(3):230-233. 被引量:12
-
3蒋宋薇,徐红,梁秀就,何中慧.子宫内膜癌组织PTEN和c-erbB-2蛋白表达临床意义的探讨[J].中华肿瘤防治杂志,2009,16(16):1246-1249. 被引量:3
-
4韦永琼,曾照芳.前凋亡因子与脑血管疾病的关系研究[J].生物信息学,2009,7(3):178-180.
-
5伏代刚,黄晓丽,甘华田,张德奎,赵立强.PTEN/PI3K/AKT在溃疡性结肠炎炎症-肿瘤序列演进中的作用[J].四川大学学报(医学版),2009,40(6):1021-1023. 被引量:8
-
1韩永华.前列腺癌抑癌基因PTEN的研究[J].国外医学(临床生物化学与检验学分册),2002,23(1):28-29.
-
2唐卫中,高枫,唐宗江,罗国容.大肠良恶性肿瘤PTEN/MMAC1/TEP1肿瘤抑制基因的蛋白表达研究[J].大肠肛门病外科杂志,2001,7(2):9-13. 被引量:10
-
3孙长成,孔垂泽,李泽良,王侠,杨春明.肾癌组织中Pten/MMAC1/Tep1的表达及临床意义[J].中华肿瘤防治杂志,2007,14(11):847-849. 被引量:3
-
4张蕾,刘彤华,刘鸿瑞,高洁,顾长芳.PTEN/MMAC1/TEP1在肺癌中的丢失和失活[J].中华病理学杂志,2000,29(2):85-88. 被引量:27
-
5刘延菊,曹明耀,姚智.抑癌基因PTEN与乳腺癌的研究进展[J].中国全科医学,2004,7(20):1536-1538. 被引量:6
-
6张勤,姜继勇.Survivin与PTEN在子宫内膜癌中的表达[J].中国冶金工业医学杂志,2012,29(4):415-416.
-
7倪建华,辛军,辛明华.肿瘤抑制基因PTEN/MMAC1/TEP1的研究现状及展望[J].现代医药卫生,2010,26(24):3755-3757.
-
8姚勤,戴淑真.PTEN/MMAC1/TEP1与妇科肿瘤[J].现代妇产科进展,2000,9(6):459-461.
-
9臧传波.抑癌基因PTEN/MMAC1/TEP1的研究进展[J].当代医学,2000,6(7):63-66. 被引量:1
-
10李金雨,曹润福,汪鸿,谢庆祥,王共先,熊礼生,缪友仁.抑癌基因PTEN/MMAC1/TEP1在肾癌组织中的表达及其与细胞增殖和凋亡的关系[J].癌症,2003,22(6):607-611. 被引量:7